IRIS
GIACOPPO, DANIELE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 1.774
NA - Nord America 1.727
EU - Europa 1.049
SA - Sud America 328
AF - Africa 73
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 4.955
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.686
SG - Singapore 772
CN - Cina 602
RU - Federazione Russa 548
IT - Italia 294
BR - Brasile 276
KR - Corea 177
VN - Vietnam 95
UA - Ucraina 58
IE - Irlanda 45
HK - Hong Kong 32
BJ - Benin 29
CA - Canada 27
CI - Costa d'Avorio 26
IN - India 22
AR - Argentina 21
NL - Olanda 18
BD - Bangladesh 17
FI - Finlandia 12
GB - Regno Unito 12
AT - Austria 10
ID - Indonesia 10
MX - Messico 10
ZA - Sudafrica 10
ES - Italia 9
TR - Turchia 9
EC - Ecuador 8
PL - Polonia 8
SE - Svezia 8
CO - Colombia 7
IR - Iran 6
DE - Germania 5
IQ - Iraq 5
PY - Paraguay 5
VE - Venezuela 4
AZ - Azerbaigian 3
BE - Belgio 3
BY - Bielorussia 3
CH - Svizzera 3
JP - Giappone 3
MA - Marocco 3
PK - Pakistan 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
BG - Bulgaria 2
CL - Cile 2
EG - Egitto 2
FR - Francia 2
IL - Israele 2
JM - Giamaica 2
LT - Lituania 2
PE - Perù 2
PH - Filippine 2
UY - Uruguay 2
UZ - Uzbekistan 2
AU - Australia 1
BO - Bolivia 1
CY - Cipro 1
CZ - Repubblica Ceca 1
GR - Grecia 1
HN - Honduras 1
JO - Giordania 1
KE - Kenya 1
KH - Cambogia 1
KI - Kiribati 1
KZ - Kazakistan 1
LB - Libano 1
MG - Madagascar 1
MK - Macedonia 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
OM - Oman 1
QA - Qatar 1
RO - Romania 1
RS - Serbia 1
SA - Arabia Saudita 1
SN - Senegal 1
TH - Thailandia 1
TJ - Tagikistan 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 4.955
Salva come PNG Salva come JPEG
Città #
Dallas 446
Santa Clara 432
Singapore 405
Hefei 351
Moscow 219
Seoul 177
Civitanova Marche 120
Chicago 103
Boardman 76
Ashburn 69
Jacksonville 64
Los Angeles 57
Dublin 45
Catania 38
Beijing 34
São Paulo 33
Chandler 32
Hong Kong 32
Cotonou 29
Abidjan 26
Buffalo 26
Ho Chi Minh City 26
Milan 25
Nanjing 21
Hanoi 18
New York 14
Andover 13
Rome 13
Toronto 13
Cambridge 12
Lawrence 12
Palermo 11
Amsterdam 9
Brooklyn 9
Chennai 8
Houston 8
Lappeenranta 8
Phoenix 8
Redondo Beach 8
San Mateo 8
Warsaw 8
Boston 7
San Francisco 7
Wilmington 7
Biên Hòa 6
Mascalucia 6
Naples 6
Orem 6
Ottawa 6
Porto Alegre 6
Rio de Janeiro 6
Tehran 6
Ankara 5
Bari 5
Brasília 5
Curitiba 5
Denver 5
Des Moines 5
Hebei 5
Jiaxing 5
London 5
Mexico City 5
Salvador 5
Shenyang 5
Stockholm 5
Turin 5
Atlanta 4
Bernareggio 4
Campinas 4
Can Tho 4
Dong Ket 4
Haiphong 4
Helsinki 4
Johannesburg 4
Messina 4
Montreal 4
Nanchang 4
Sorocaba 4
Washington 4
Agerola 3
Baku 3
Barcelona 3
Bắc Giang 3
Bắc Ninh 3
Contagem 3
Council Bluffs 3
Dhaka 3
Elk Grove Village 3
Guarulhos 3
Guayaquil 3
Honolulu 3
Itaquaquecetuba 3
Mauá 3
Minsk 3
New Delhi 3
Norwalk 3
Poplar 3
Recife 3
Salzburg 3
San Cipriano Po 3
Totale 3.320
Salva come PNG Salva come JPEG
Nome #
Pharmacological and Clinical Appraisal of Factor XI Inhibitor Drugs. 122
Coronary Angiography, Intravascular Ultrasound, and Optical Coherence Tomography in the Guidance of Percutaneous Coronary Intervention: A Systematic Review and Network Meta-Analysis. 121
Antithrombotic Therapy for Primary and Secondary Prevention of Ischemic Stroke : JACC State-of-the-Art Review 119
Temporal patterns of early neointimal strut coverage of the CATANIA stent compared with drug eluting stents and bare metal stent: the Rapid Evaluation of Vessel Healing after Angioplasty (REVEAL) trial 100
PCSK9 inhibitors: current status and emerging frontiers in lipid control 92
Balancing the Risk of Bleeding and Stroke in Patients With Atrial Fibrillation After Percutaneous Coronary Intervention (from the AVIATOR Registry) 92
Characteristics and Impact of Randomized Trials on Drugs or Devices in Cardiovascular Medicine 90
Spontaneous coronary artery dissection 88
Preventive Strategies for Contrast-Induced Acute Kidney Injury in Patients Undergoing Percutaneous Coronary Procedures: Evidence from a Hierarchical Bayesian Network Meta-Analysis of 124 Trials and 28 240 Patients 84
Short and mid-term benefits of coronary stent system with nanothin Polyzene-F in acute coronary syndromes: preliminary result 81
Treatment strategies for coronary in-stent restenosis: systematic review and hierarchical Bayesian network meta-analysis of 24 randomised trials and 4880 patients. 79
Meta-Analyses of Dual Antiplatelet Therapy Following Drug-Eluting Stent Implantation: Do Bleeding and Stent Thrombosis Weigh Similar on Mortality? 78
Response by Giacoppo et al to Letter Regarding Article “Coronary Angiography, Intravascular Ultrasound, and Optical Coherence Tomography for Guiding of Percutaneous Coronary Intervention: A Systematic Review and Network Meta-Analysis” 77
Applied coronary physiology for planning and guidance of percutaneous coronary interventions. A clinical consensus statement from the European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the European Society of Cardiology. 77
Lipoprotein(a) as a Pharmacological Target: Premises, Promises, and Prospects 77
Mid-term clinical outcome of Catania coronary stent system with nanothin Polyzene-F in a real world unselected population: preliminary results 75
Safety and effectiveness of the Catania Polyzene-F coated stent in real world clinical practice: 12-month results from the ATLANTA 2 registry 75
Coronary Drug-Coated Balloons for De Novo and In-Stent Restenosis Indications. 74
Current developments in dual antiplatelet therapy after stenting 74
Association between surgical risk and 30‐day stroke after transcatheter versus surgical aortic valve replacement: a systematic review and meta‐analysis. 74
Anticoagulation After Transcatheter Aortic Valve Replacement 73
A pairwise and network meta-analysis of anti-inflammatory strategies after myocardial infarction: the TITIAN study 72
Coronary artery restenosis treatment with plain balloon, drug-coated balloon, or drug-eluting stent: 10-year outcomes of the ISAR-DESIRE 3 trial 71
Changes in high-sensitivity troponin after drug-coated balloon angioplasty for drug-eluting stent restenosis. 71
Acute kidney injury after endovascular interventions for critical limb ischemia: Is that a whole different animal? 68
Objectifying the impact of incomplete revascularization by repeat angiographic risk assessment with the residual SYNTAX score after left main coronary artery percutaneous coronary intervention. 68
Usefulness of the logistic clinical SYNTAX score for predicting 1-year mortality in patients undergoing percutaneous coronary intervention of the left main coronary artery 67
Meta-analysis of Randomized Controlled Trials of Preprocedural Statin Administration for Reducing Contrast Induced Acute Kidney In Patients Undergoing Coronary Catheterization 67
Current Management of In-Stent Restenosis 65
Safety and efficacy of minimalist transcatheter aortic valve implantation using a new-generation balloon-expandable transcatheter heart valve in bicuspid and tricuspid aortic valves. 65
Changes in Coagulation Factor XI Activity Levels in Patients with ST-Segment Elevation Myocardial Infarction Undergoing Primary PCI 65
Antiplatelet Therapy in Patients Requiring Oral Anticoagulation and Undergoing Percutaneous Coronary Intervention 64
Five-year clinical outcomes in patients with diabetes mellitus treated with polymer-free sirolimus- and probucol-eluting stents versus second-generation zotarolimus-eluting stents: a subgroup analysis of a randomized controlled trial. 63
Drug-coated balloon angioplasty for in-stent restenosis of femoropopliteal arteries: a meta-analysis 63
Drug-Coated Balloon Angioplasty Versus Drug-Eluting Stent Implantation in Patients With Coronary Stent Restenosis. 63
Meta-Analysis of Short vs. Prolonged Dual Antiplatelet Therapy after Drug-Eluting Stent Implantation and Role of Continuation with either Aspirin or a P2Y12 Inhibitor Thereafter 61
Do outcomes following intervention for drug-eluting stent restenosis depend on whether the restenosed stent was polymer-free or polymer-coated? 61
Management of in-stent restenosis 61
Five‐year follow‐up of polymer‐free sirolimus‐ and probucol‐eluting stents versus new generation zotarolimus‐eluting stents in patients presenting with st‐elevation myocardial infarction 60
Mid-term clinical outcome of CATANIA Coronary stent system with nanothin Polyzene-F in a real world unselected population: preliminary results 60
Short dual antiplatelet therapy followed by P2Y12 inhibitor monotherapy vs. prolonged dual antiplatelet therapy after percutaneous coronary intervention with second-generation drug-eluting stents: a systematic review and meta-analysis of randomized clinical trials 58
Completeness, timing, and guidance of percutaneous coronary intervention for myocardial infarction and multivessel disease: a systematic review and network meta-analysis 58
Evaluation of a Low-Dose Radiation Protocol During Transcatheter Aortic Valve Implantation 57
Dual antiplatelet therapy de-escalation by discontinuation in patients with ST-segment elevation myocardial infarction: a systematic review and meta-analysis 57
Vascular response to percutaneous coronary intervention with biodegradable-polymer vs. new-generation durable-polymer drug-eluting stents: a meta-analysis of optical coherence tomography imaging trials 56
Percutaneous Coronary Intervention vs Coronary Artery Bypass Grafting in Patients With Left Main Coronary Artery Stenosis. 56
Paclitaxel-coated balloon angioplasty vs. drug-eluting stenting for the treatment of coronary in-stent restenosis: a comprehensive, collaborative, individual patient data meta-analysis of 10 randomized clinical trials (DAEDALUS study). 56
Intraindividual Comparison of Everolimus-Eluting Bioresorbable Vascular Scaffolds Versus Drug-Eluting Metallic Stents 54
Expanding indications for drug-coated balloons in coronary artery disease 54
Effects on Mortality and Major Bleeding of Radial Versus Femoral Artery Access for Coronary Angiography or Percutaneous Coronary Intervention: Meta-Analysis of Individual Patient Data From 7 Multicenter Randomized Clinical Trials. 53
The Rapid Evaluation of Vessel Healing after Angioplasty (REVEAL) trial 52
Outcomes of patients treated with durable polymer platinum-chromium everolimus-eluting stents: a meta-analysis of randomised trials. 52
Management of myocardial revascularisation failure: an expert consensus document of the EAPCI 51
Should we routinely use ultrasound-guided transfemoral access for coronary procedures? High-quality evidence from an individual participant data meta-analysis. 51
Transcatheter aortic valve replacement for bicuspid aortic valve stenosis with first- and new-generation bioprostheses: A systematic review and meta-analysis. 51
Transcatheter versus surgical aortic valve replacement in the digital era: Meta‐analysis based on the reconstruction of time‐to‐event individual patient data. 50
Validation of the DAPT score in patients randomized to 6 or 12 months clopidogrel after predominantly second-generation drug-eluting stents. 49
Optimal periprocedural antithrombotic therapy in percutaneous coronary intervention: Between a rock and a hard place? 48
Management of Patients Treated With Oral Anticoagulant Therapy Undergoing Percutaneous Coronary Intervention With Stent Implantation: The PERSEO Registry 48
Risk of stroke, atrial fibrillation, and major bleeding after mitral valve repair: the jury is still out. 48
Incidence, Patterns, and Associations Between Dual-Antiplatelet Therapy Cessation and Risk for Adverse Events Among Patients With and Without Diabetes Mellitus Receiving Drug-Eluting Stents. 45
P2Y 12 inhibitor or aspirin after percutaneous coronary intervention: individual patient data meta-analysis of randomised clinical trials 44
Incidence and impact of acute kidney injury in patients with acute coronary syndromes treated with coronary artery bypass grafting: Insights from the Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction (HORIZONS-AMI) and Acute Catheterization and Urgent Intervention Triage Strategy (ACUITY) trials 44
Angiographic and clinical outcomes of patients treated with drug-coated balloon angioplasty for in-stent restenosis after coronary bifurcation stenting with a two-stent technique. 44
Untangling the knot of the best endovascular treatment for femoropopliteal artery disease 43
Prognostic Value of Cardiac Troponin T and Sex in Patients Undergoing Elective Percutaneous Coronary Intervention 41
Koronare Herzerkrankung mit Hauptstammbeteiliung 41
Anti-inflammatory pharmacotherapy in patients with cardiovascular disease 40
One-month DAPT after biodegradable-polymer everolimus-eluting stent implantation in patients at high-bleeding risk: an individual patient data pooled analysis of the SENIOR and POEM trials 40
Impact of stent size on angiographic and clinical outcomes after implantation of everolimus-eluting bioresorbable scaffolds in daily practice: insights from the ISAR-ABSORB registry 39
Drug-Coated Balloon Versus Plain Balloon Angioplasty for the Treatment of Femoropopliteal Artery Disease. 37
Long-term effectiveness and safety of transcatheter closure of patent foramen ovale compared with antithrombotic therapy alone: a meta-analysis of six randomised clinical trials and 3,560 patients with reconstructed time-to-event data 37
Reply: Completeness or complexity? A nuanced reflection on multivessel revascularisation 37
Targeting Inflammation After Acute Myocardial Infarction 36
Long-Term Antithrombotic Therapy in Patients with Atrial Fibrillation and Percutaneous Coronary Intervention 35
Advances in the Detection and Management of Vulnerable Coronary Plaques 34
Trends in transcatheter aortic valve implantation practice and clinical outcomes at an Irish tertiary referral centre 34
Paclitaxel- or sirolimus-coated balloons for coronary bifurcations: is the side branch SPACIOUS enough for both? 34
Gli stent coronarici a rilascio di farmaco nella pratica interventistica contemporanea: progetto STENT PANORAMA (Parte I) 32
Predicting the risk of in-stent restenosis after drug-eluting stent implantation: Pipe dream or machine learning-enabled opportunity? 31
Individual patient data meta-analysis of paclitaxel-coated balloons vs. drug-eluting stents for small-vessel coronary artery disease: the ANDROMEDA study 29
Off TARGET Effects in Stent Comparison Trials 27
Prasugrel monotherapy versus standard DAPT in STEMI patients with OCT-guided or angio-guided complete revascularisation: design and rationale of the randomised, multifactorial COMPARE STEMI ONE trial 27
Molecular multimodality imaging: has a long-standing dream come true? 25
Radial artery access among mainstays of contemporary percutaneous coronary intervention: Is it time to forget how to puncture a femoral artery? 24
Impact of bystander-initiated cardiopulmonary resuscitation for out-of-hospital cardiac arrest: where would you be happy to have a cardiac arrest? 23
High-risk percutaneous coronary intervention in patients with reduced left ventricular ejection fraction deemed not suitable for surgical revascularisation. A clinical consensus statement from the European Association of Percutaneous Cardiovascular Interventions (EAPCI) in collaboration with the ESC Working Group on Cardiovascular Surgery 18
Totale 5.057
Salva come PNG Salva come JPEG
Categoria #
all - tutte 14.975
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.975
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202136 0 0 0 0 0 0 12 0 8 0 12 4
2021/202290 12 13 1 0 16 0 13 6 10 0 2 17
2022/2023127 12 1 1 9 20 21 0 18 40 1 0 4
2023/2024246 1 14 4 14 1 10 0 70 12 14 63 43
2024/20251.483 16 174 53 137 328 200 72 30 99 105 92 177
2025/20262.918 350 595 542 265 598 568 0 0 0 0 0 0
Totale 5.057